Human organoid biofilm model for assessing antibiofilm activity of novel agents
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Bacterial biofilms cause 65% of all human infections and are highly resistant to antibiotic therapy but lack specific treatments. To provide a human organoid model for studying host-microbe interplay and enabling screening for novel antibiofilm agents, a human epidermis organoid model with robust methicillin-resistant Staphylococcus aureus (MRSA) USA300 and Pseudomonas aeruginosa PAO1 biofilm was developed. Treatment of 1-day and 3-day MRSA and PAO1 biofilms with antibiofilm peptide DJK-5 significantly and substantially reduced the bacterial burden. This model enabled the screening of synthetic host defense peptides, revealing their superior antibiofilm activity against MRSA compared to the antibiotic mupirocin. The model was extended to evaluate thermally wounded skin infected with MRSA biofilms resulting in increased bacterial load, cytotoxicity, and pro-inflammatory cytokine levels that were all reduced upon treatment with DJK-5. Combination treatment of DJK-5 with an anti-inflammatory peptide, 1002, further reduced cytotoxicity and skin inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long‐term expanding human airway organoids for disease modeling
Sachs, N., Papaspyropoulos, A., Zomer‐van Ommen, D. D., Heo, I., Böttinger, L., Klay, D., Weeber, F., Huelsz‐Prince, G., Iakobachvili, N., Amatngalim, G. D., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100300 · Cited by 1,082
Strategies for combating bacterial biofilm infections
Wu, H., Moser, C., Wang, H.-Z., Høiby, N., & Song, Z.-J. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2014.65 · Cited by 925
Control of Cell Morphogenesis in Bacteria
Daniel, R. A., & Errington, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00421-5 · Cited by 740
Translation of Research Evidence From Animals to Humans
Hackam, D. G., & Redelmeier, D. A. (2006) · JAMA · doi:10.1001/jama.296.14.1731 · Cited by 733
Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development
Ronaldson-Bouchard, K., & Vunjak-Novakovic, G. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.02.011 · Cited by 657
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms
de Breij, A., Riool, M., Cordfunke, R. A., Malanovic, N., de Boer, L., Koning, R. I., Ravensbergen, E., Franken, M., van der Heijde, T., Boekema, B. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4044 · Cited by 555
Self-citationBiofilms and Inflammation in Chronic Wounds
Zhao, G., Usui, M. L., Lippman, S. I., James, G. A., Stewart, P. S., Fleckman, P., & Olerud, J. E. (2013) · Advances in Wound Care · doi:10.1089/wound.2012.0381 · Cited by 448
Translation of highly promising basic science research into clinical applications
Contopoulos-Ioannidis, D. G., Ntzani, E. E., & Ioannidis, J. P. A. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00013-5 · Cited by 323
Skin barrier defects in atopic dermatitis
Agrawal, R., & Woodfolk, J. A. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0433-9 · Cited by 201
Effect of Human Burn Wound Exudate on Pseudomonas aeruginosa Virulence
Gonzalez, M. R., Fleuchot, B., Lauciello, L., Jafari, P., Applegate, L. A., Raffoul, W., Que, Y.-A., & Perron, K. (2016) · mSphere · doi:10.1128/msphere.00111-15 · Cited by 109
Cited by
The biofilm life cycle: expanding the conceptual model of biofilm formation
Sauer, K., Stoodley, P., Goeres, D. M., Hall-Stoodley, L., Burmølle, M., Stewart, P. S., & Bjarnsholt, T. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00767-0 · Cited by 1,404
Antibiofilm activity of host defence peptides: complexity provides opportunities
Hancock, R. E. W., Alford, M. A., & Haney, E. F. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00585-w · Cited by 270
Self-citationAntibiotic failure: Beyond antimicrobial resistance
de la Fuente-Nunez, C., Cesaro, A., & Hancock, R. E. W. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101012 · Cited by 254
Self-citationChe, J., Shi, J., Fang, C., Zeng, X., Wu, Z., Du, Q., Tu, M., & Pan, D. (2024) · Microorganisms · doi:10.3390/microorganisms12040704 · Cited by 52
“Bacterial or fungal biofilms are also widely known to contribute to chronic human infections and diseases [19], such as lung and urinary tract infection [20,21] and skin and gastrointestinal inflammation [22], which cannot be effectively treated using conventional antibiotics.”
BackgroundQiu, D., Zheng, C., Zeng, Y., Wu, L., Huang, C., Ran, Y., Ding, Y., Shi, J., Cai, X., & Pan, Y. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.147217 · Cited by 40
Metadata
- Authors
- Wu, B., Haney, E. F., Akhoundsadegh, N., Pletzer, D., Trimble, M. J., Adriaans, A. E., Nibbering, P. H., & Hancock, R. E. W.
- Venue
- npj Biofilms and Microbiomes
- Published
- 2021-01-25
- Volume
- 7
- Issue
- 1
- Pages
- 8-8
- ISSN
- 2055-5008 (ISSN-L)
- OpenAlex
- W3124285638
- Cited by
- 61
- References
- 11
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human organoid biofilm model for assessing antibiofilm activity of novel agents. https://app.cochat.ai/papers/10.1038/s41522-020-00182-4
- The paper
- Wu, B., Haney, E. F., Akhoundsadegh, N., Pletzer, D., Trimble, M. J., Adriaans, A. E., Nibbering, P. H., & Hancock, R. E. W. (2021). Human organoid biofilm model for assessing antibiofilm activity of novel agents. npj Biofilms and Microbiomes. https://doi.org/10.1038/s41522-020-00182-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.